| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |